Buy Genprex Stock | GNPX Stock Price & Latest News | Public.com
GNPX

Genprex

$0.00 (0.00%)Today
    Small Market Cap
    View Genprex (GNPX) stock trends here

    About GNPX

    Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.14
    -0.21
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.12

    Actual EPS
    Q2 2021

    Stats

    Market Cap$157,09M
    Volume1,85k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.72
    1 Year Low$2.56
    Open$3.70
    High$3.81
    Low$3.48

    Buy any stock with any amount of money.

    Download the App
    Download the app